Clinical Trial Update: Efficacy of Low Analgesic Doses of Ketamine Associated With Opioids in Refractory Cancer Pain Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating low-dose ketamine in combination with opioids for refractory cancer pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Cancer Pain

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pain | Phase 3 | Status: COMPLETED